• 1. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 2. Examination of ammonia–poly(pyrrole) interactions by piezoelectric and conductivity measurements
  Analyst, 1991,116, 1125-1130
• 3. Excellent electrochemical performance of LiFe0.4Mn0.6PO4 microspheres produced using a double carbon coating process?
  Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837
• 4. Dissociative electron attachment to HGaF4 Lewis–Br?nsted superacid
  Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745
• 5. Elusive 2-aminofuran Diels–Alder substrates for a straightforward synthesis of polysubstituted anilines?
  Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555

• Solvents and Organic Chemicals Organic Compounds Benzenoids Naphthalenes Naphthalene sulfonic acids and derivatives 2-naphthalene sulfonic acids and derivatives

Professional Introduction to N-2-(dimethylamino)-2-(furan-2-yl)ethylnaphthalene-2-sulfonamide (CAS No. 899955-47-6)

N-2-(dimethylamino)-2-(furan-2-yl)ethylnaphthalene-2-sulfonamide, with the CAS number 899955-47-6, is a sophisticated organic compound that has garnered significant attention in the field of chemical and pharmaceutical research. This compound belongs to a class of molecules that exhibit promising biological activities, making it a subject of extensive study in medicinal chemistry and drug development.

The molecular structure of N-2-(dimethylamino)-2-(furan-2-yl)ethylnaphthalene-2-sulfonamide is characterized by its unique combination of functional groups, including a naphthalene core, a dimethylamino substituent, and a furan moiety. These structural elements contribute to its distinct chemical properties and potential biological interactions. The naphthalene ring, known for its stability and aromaticity, serves as a scaffold for further functionalization, while the dimethylamino group introduces basicity and potential hydrogen bonding capabilities. The furan ring, on the other hand, adds an oxygen atom into the molecular framework, which can influence both the electronic distribution and solubility characteristics of the compound.

In recent years, there has been a growing interest in developing novel sulfonamide derivatives as potential therapeutic agents. Sulfonamides are well-known for their broad spectrum of biological activities, including antimicrobial, anti-inflammatory, and anticancer properties. The introduction of additional functional groups, such as the dimethylamino and furan moieties in N-2-(dimethylamino)-2-(furan-2-yl)ethylnaphthalene-2-sulfonamide, aims to enhance these properties and explore new pharmacological targets.

One of the most compelling aspects of this compound is its potential application in oncology research. Recent studies have demonstrated that molecules with similar structural motifs can interact with specific enzymes and receptors involved in cancer cell proliferation and survival. The combination of the naphthalene core with the electron-withdrawing effects of the sulfonamide group may facilitate binding to key targets such as kinases and transcription factors. Furthermore, the presence of the dimethylamino group could enhance solubility and bioavailability, which are critical factors for drug efficacy.

Another area of interest is the antimicrobial activity of N-2-(dimethylamino)-2-(furan-2-yl)ethylnaphthalene-2-sulfonamide. Antibiotic resistance remains a significant global health challenge, prompting researchers to explore new chemical entities that can combat resistant bacterial strains. The sulfonamide moiety is known to disrupt bacterial metabolic pathways, particularly by inhibiting dihydropteroate synthase. By incorporating additional structural elements like the furan ring, researchers aim to expand the spectrum of activity and reduce the likelihood of resistance development.

The synthesis of N-2-(dimethylamino)-2-(furan-2-yl)ethylnaphthalene-2-sulfonamide presents unique challenges due to its complex structure. However, advances in synthetic methodologies have made it possible to construct such molecules with high precision. Techniques such as multi-step organic synthesis, including cross-coupling reactions and nucleophilic substitutions, have been employed to introduce the desired functional groups at specific positions on the naphthalene core. These synthetic strategies ensure that the final product retains its intended biological activity while maintaining structural integrity.

In vitro studies have begun to uncover the mechanistic aspects of N-2-(dimethylamino)-2-(furan-2-yl)ethylnaphthalene-2-sulfonamide. Initial experiments suggest that it can interact with target proteins through non-covalent interactions such as hydrogen bonding and hydrophobic interactions. The dimethylamino group may form hydrogen bonds with acidic residues on the protein surface, while the furan ring could engage in π-stacking interactions with aromatic amino acids. These interactions are crucial for determining binding affinity and specificity.

Furthermore, computational studies using molecular modeling techniques have provided valuable insights into the binding mode of this compound. These simulations help predict how N-2-(dimethylamino)-2-(furan-2-yl)ethylnaphthalene-2-sulfonamide might interact with biological targets at an atomic level. By understanding these interactions in detail, researchers can optimize the molecule's structure to improve its pharmacological properties.

The potential therapeutic applications of this compound extend beyond oncology and antimicrobial treatments. There is growing evidence suggesting that sulfonamide derivatives may have utility in neurological disorders due to their ability to cross the blood-brain barrier and interact with central nervous system receptors. The unique structural features of N-2-(dimethylamino)-2-(furan-2-yl)ethylnaphthalene-2-sulfonamide make it an attractive candidate for further investigation in this area.

In conclusion, N-2-(dimethylamino)-2-(furan-2-yloxy)ethylnaphthalene sulfonamide (CAS No. 899955476) represents a promising chemical entity with diverse potential applications in pharmaceutical research. Its complex structure and unique functional groups position it as a valuable tool for exploring new therapeutic strategies across multiple disease areas. As research continues to uncover its biological activities and mechanisms of action, this compound is likely to play an important role in future drug development efforts.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)